208 related articles for article (PubMed ID: 15163259)
1. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.
Lamberti JS; Crilly JF; Maharaj K; Olson D; Wiener K; Dvorin S; Costea GO; Bushey MP; Dietz MB
J Clin Psychiatry; 2004 May; 65(5):702-6. PubMed ID: 15163259
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
4. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use.
Lévy E; Margolese HC; Annable L; Chouinard G
Can J Psychiatry; 2004 Jun; 49(6):398-402. PubMed ID: 15283536
[TBL] [Abstract][Full Text] [Related]
5. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
6. Race and long-acting antipsychotic prescription at a community mental health center: a retrospective chart review.
Aggarwal NK; Rosenheck RA; Woods SW; Sernyak MJ
J Clin Psychiatry; 2012 Apr; 73(4):513-7. PubMed ID: 22579151
[TBL] [Abstract][Full Text] [Related]
7. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
Henderson DC; Cagliero E; Copeland PM; Louie PM; Borba CP; Fan X; Freudenreich O; Goff DC
J Clin Psychiatry; 2007 Apr; 68(4):533-41. PubMed ID: 17474808
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes mellitus and atypical antipsychotics].
de Sena EP; Sampaio AS; Quarantini Lde C; Oliveira IR
Braz J Psychiatry; 2003 Oct; 25(4):253-7. PubMed ID: 15328554
[TBL] [Abstract][Full Text] [Related]
9. Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study.
Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
Lancet Psychiatry; 2015 Dec; 2(12):1092-8. PubMed ID: 26477242
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
12. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database.
Kornegay CJ; Vasilakis-Scaramozza C; Jick H
J Clin Psychiatry; 2002 Sep; 63(9):758-62. PubMed ID: 12363114
[TBL] [Abstract][Full Text] [Related]
13. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ; Gulanski B; Rosenheck R
J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
[TBL] [Abstract][Full Text] [Related]
14. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
15. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
[TBL] [Abstract][Full Text] [Related]
16. Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans.
Barner JC; Worchel J; Yang M
Pharmacotherapy; 2004 Nov; 24(11):1529-38. PubMed ID: 15537558
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study.
Jennex A; Gardner DM
Can J Psychiatry; 2008 Jan; 53(1):34-42. PubMed ID: 18286870
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
[TBL] [Abstract][Full Text] [Related]
19. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
20. Association between antipsychotic drugs and diabetes.
Holt RI; Peveler RC
Diabetes Obes Metab; 2006 Mar; 8(2):125-35. PubMed ID: 16448516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
